428 results
Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor
Proteins, Antibodies & ADCs

Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor

Technology Spotlight
Apr , 2026
Interview with James Keck, Vice President of Innovation and Product Development, The Jackson Laboratory
Cell & Gene

Interview with James Keck, Vice President of Innovation and Product Development, The Jackson Laboratory

Technology Spotlight
Apr , 2026
Peptides

Interview with Hans Melo

Thought Leadership
Apr , 2026
Proteins, Antibodies & ADCs

Interview with Karen Silence

Thought Leadership
Apr , 2026
Interview with Ilse Roodink, CSO, AVS Bio

Interview with Ilse Roodink, CSO, AVS Bio

News
Apr , 2026
Interview with Nick Challoner, CEO, Ingenza

Interview with Nick Challoner, CEO, Ingenza

News
Apr , 2026
Interview with Charlotte Deane
Proteins, Antibodies & ADCs

Interview with Charlotte Deane

News
Mar , 2026
Interview with Karen Silence
Proteins, Antibodies & ADCs

Interview with Karen Silence

News
Mar , 2026
Interview with Professor Morten Meldal
Cell & Gene

Interview with Professor Morten Meldal

News
Feb , 2026
Thought Leadership Webinar: Ten Years of the Human Cell Atlas: A Decade Transforming Regenerative Medicine
Cell & Gene

Thought Leadership Webinar: Ten Years of the Human Cell Atlas: A Decade Transforming Regenerative Medicine

News
Feb , 2026
Interview with Andreas Plückthun
Proteins, Antibodies & ADCs

Interview with Andreas Plückthun

News
Feb , 2026
Interview with Andreas Plückthun
Proteins, Antibodies & ADCs

Interview with Andreas Plückthun

Thought Leadership
Feb , 2026
Interview with Alexander Eggermont
Cell & Gene

Interview with Alexander Eggermont

News
Feb , 2026
Cell & Gene

Interview with Alexander Eggermont

Thought Leadership
Feb , 2026
Delivering Next Generation Regenerative Medicine
Cell & Gene

Delivering Next Generation Regenerative Medicine

News
Jan , 2026
Delivering Next Generation Regenerative Medicine
Cell & Gene

Delivering Next Generation Regenerative Medicine

Thought Leadership
Jan , 2026
Top 25 of ’25: NextGen Biomed eBook

Top 25 of ’25: NextGen Biomed eBook

News
Jan , 2026
Ianalumab Effective for Immune Thrombocytopenia in Phase III
Proteins, Antibodies & ADCs

Ianalumab Effective for Immune Thrombocytopenia in Phase III

News
Dec , 2025
Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

News
Dec , 2025

Delivering Next-Generation Regenerative Medicine: Bioengineering, Clinical Translation & the Future of Therapeutics

Announcement
Dec , 2025
Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures
Cell & Gene

Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures

News
Dec , 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.